NIH IMPROVE Act (H.R. 6238)

Summary

Establishes a program at the National Institutes of Health to research and reduce the causes of maternal death and serious illness, especially in certain groups.

What problem does this solve?

Many women in the U.S. die or get very sick from causes related to pregnancy, and some groups are affected more than others. This bill creates a research program to find out why this happens and test ways to make pregnancy safer for everyone.

What does this bill do?

Establishes the IMPROVE Initiative

Creates a formal program within the National Institutes of Health (NIH) called the 'IMPROVE Initiative' to focus on improving maternal health.

Sets research goals

Directs the initiative to research ways to reduce preventable maternal deaths, lessen health disparities among different groups, and improve health for women before, during, and after pregnancy.

Authorizes funding

Approves $73,400,000 for each fiscal year from 2026 through 2031 to carry out the initiative's research and activities.

Focuses on community-based solutions

Requires the program to test and evaluate health solutions within communities that are most affected by high rates of maternal death and severe illness.

Who does this affect?

Pregnant and postpartum women
Medical researchers
Public health officials

What is the real world impact?

•

Addresses a public health crisis

Directs federal research power towards understanding and preventing the high rates of maternal death and severe illness in the United States, a significant problem compared to other developed nations.

•

Promotes health equity

Focuses research on why certain groups of women face much higher risks during and after pregnancy. Aims to find and test community-based solutions to reduce these unfair health differences.

When does this start?

The initiative would begin as soon as the bill becomes law, with specific funding authorized for future years.

Program funding

Authorizes $73,400,000 for the program for each fiscal year from 2026 through 2031.